These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 28377431)

  • 1. The renal and cardiovascular effects of natriuretic peptides.
    Wong PC; Guo J; Zhang A
    Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
    Nougué H; Pezel T; Picard F; Sadoune M; Arrigo M; Beauvais F; Launay JM; Cohen-Solal A; Vodovar N; Logeart D
    Eur J Heart Fail; 2019 May; 21(5):598-605. PubMed ID: 30520545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.
    Díez J
    Eur J Heart Fail; 2017 Feb; 19(2):167-176. PubMed ID: 27766748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
    Chen HH; Burnett JC
    Proc Assoc Am Physicians; 1999; 111(5):406-16. PubMed ID: 10519161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    Myhre PL; Vaduganathan M; Claggett B; Packer M; Desai AS; Rouleau JL; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2019 Mar; 73(11):1264-1272. PubMed ID: 30846338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heart, an endocrine gland: Natriuretic peptides.
    Lemaitre M; Jannin A; Chevalier B; Vantyghem MC
    Ann Endocrinol (Paris); 2022 Feb; 83(1):59-62. PubMed ID: 34871602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.
    Ibrahim NE; McCarthy CP; Shrestha S; Gaggin HK; Mukai R; Szymonifka J; Apple FS; Burnett JC; Iyer S; Januzzi JL
    J Am Coll Cardiol; 2019 Mar; 73(11):1273-1284. PubMed ID: 30898202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting and Modulation of the Natriuretic Peptide System in Covid-19: A Single or Double-Edged Effect?
    Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Batiha GE
    Curr Protein Pept Sci; 2022; 23(5):321-334. PubMed ID: 35762551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.
    Chrysant SG
    J Am Soc Hypertens; 2017 Jul; 11(7):461-468. PubMed ID: 28652105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial and brain natriuretic peptides: Hormones secreted from the heart.
    Nakagawa Y; Nishikimi T; Kuwahara K
    Peptides; 2019 Jan; 111():18-25. PubMed ID: 29859763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial natriuretic peptides: diagnostic and therapeutic potential].
    Brockhoff C; Warnholtz A; Münzel T
    Ther Umsch; 2000 May; 57(5):305-12. PubMed ID: 10859990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin Receptor-Neprilysin Inhibitors and the Natriuretic Peptide Axis.
    Vasquez N; Carter S; Grodin JL
    Curr Heart Fail Rep; 2020 Jun; 17(3):67-76. PubMed ID: 32394149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Hubers SA; Brown NJ
    Circulation; 2016 Mar; 133(11):1115-24. PubMed ID: 26976916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
    Dickey DM; Potter LR
    J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides in the pathophysiology of congestive heart failure.
    Chen HH; Burnett JC
    Curr Cardiol Rep; 2000 May; 2(3):198-205. PubMed ID: 10980893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
    Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
    Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides and therapeutic applications.
    Lee CY; Burnett JC
    Heart Fail Rev; 2007 Jun; 12(2):131-42. PubMed ID: 17440808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.